Work

Abstract 1682: Novel CDK2/CDK9 inhibitor fadraciclib targets cell survival and DNA damage pathways and synergizes with encorafenib in human colorectal cancer cells with BRAF(V600E)

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-1682

Authors: Md Mohiuddin, Vanda Póvoa, Rita Fior, Frank A. Sinicrope

Institutions: Mayo Clinic, Champalimaud Foundation

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409625013

Cites:

Cited by:

Related to: 10